News
Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that the National Comprehensive Cancer Network® (NCCN®) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback